Varex Imaging Corporation (VREX)

NASDAQ: VREX · USD

$18.5

-0.01 (-0.0%)· Recorded snapshot

Market cap	777.8M
Revenue (ttm)	865M
Net income (ttm)	22.1M
EPS (ttm)	$0.52
Shares out	42.1M
P/E (trailing)	35.5x
P/E (forward)	20.3x
Volume	459,303
Beta	0.97

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 865M
Net income (ttm): 22.1M
EPS (ttm): $0.52
P/E (trailing): 35.5x
P/E (forward): 20.3x
Market cap: 777.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E20.3

P25 13.4P50 20.2P75 35.7

Trailing P/E35.5

P25 15.4P50 25.8P75 43.5

ROE4.6

P25 -113.8P50 -46.5P75 -0.9

ROIC7.5

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All VREX indicators

Market & fundamental data

Available fields

246

Groups with data

Currency

USD

Showing 246 of 246 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001681622
Company name	Varex Imaging Corporation
Country	United States
Country code	US
CUSIP number	92214X106
Earnings date	2026-11-17
Earnings time	amc
Employees	2,500
Employees change	200
Employees growth	8.7%
Enterprise value	$1.1B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-07-03
First seen	2026-05-09
Fiscal year end	October
Founded	2016
In index	RUSSELL2000
Industry	Medical Devices
Is primary listing	Yes
Is SPAC	No
ISIN number	US92214X1063
Last 10-K release date	2025-11-18
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$777.8M
Market cap category	Small-Cap
Next earnings date	2026-11-17
Options	Yes
Price	$18.46
Price currency	USD
Sector	Healthcare
SIC code	3679
Stock price date	2026-10-28
Symbol	VREX
U.S. state	Utah
Website	https://www.vareximaging.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	17.09x
Average P/E ratio (10Y)	49.23x
Average P/E ratio (5Y)	28.99x
Earnings yield	2.82%
EV/Earnings	47.82x
EV/EBIT	14.64x
EV/EBITDA	10.62x
EV/Sales	1.22x
FCF / EV yield	-1.91%
FCF yield	-2.6%
Forward EV/Sales	1.18x
Forward P/E	20.28x
Forward P/S	0.87x
Graham number	11.74081
Graham upside	-36.36%
Industry forward P/E	19.81x
Industry P/E	39.5x
Lynch fair value	$2.60
Lynch upside	-85.91%
P/B ratio	1.57x
P/E ratio	35.49x
P/OCF ratio	68.82x
P/S ratio	0.9x
PEG ratio	2.25x
Price / tangible book value	2.71x
Price/EBITDA ratio	7.82x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	8.35%
EBITDA margin	11.5%
Effective tax rate	18.77%
Gross margin	34.32%
Operating margin	8.35%
Pretax margin	3.2%
Profit margin	2.55%
Profit per employee	$8,840
Profitable quarters	1
Revenue per employee	$346,000
ROA	4.15%
ROA (5Y)	3.62%
ROCE	7.91%
ROE	4.59%
ROE (5Y)	-0.81%
ROIC	7.47%
ROIC (5Y)	-1.34%
SBC / revenue	1.73%
Tax / revenue	0.6%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth 10Y	-10.94%
EPS growth 3Y	-10.46%
EPS growth quarters	1
EPS growth years	0
FCF growth (Q)	757.14%
Gross profit growth	6.11%
Gross profit growth (Q)	13.63%
Gross profit growth 3Y	1.16%
Gross profit growth 5Y	5.46%
Net income growth 3Y	-9.08%
Net income growth quarters	1
Net income growth years	0
OCF growth	-81.07%
OCF growth (Q)	172.73%
OCF growth 10Y	-18.26%
OCF growth 3Y	-47.57%
OCF growth 5Y	-17.85%
Operating income growth	25.78%
Operating income growth (Q)	72.73%
Operating income growth 3Y	-1.48%
Operating income growth 5Y	19.6%
Revenue growth	5.31%
Revenue growth (Q)	3.7%
Revenue growth (QoQ)	-2.55%
Revenue growth 10Y	3.59%
Revenue growth 3Y	-1.22%
Revenue growth 5Y	2.57%
Revenue growth quarters	4
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-31.5M
Depreciation and amortization	$27.3M
EBIT	$72.2M
EBITDA	$99.5M
EPS	$0.52
FCF per share	$-0.48
Financing cash flow	$-31M
Free cash flow	$-20.2M
Free cash flow minus SBC	$-35.2M
Gross profit	$296.9M
Income taxes	$5.2M
Investing cash flow	$-17.8M
Net borrowing	$-24M
Net cash flow	$-37.4M
Net income	$22.1M
Operating cash flow minus SBC	$-3.7M
Operating income	$72.2M
Revenue	$865M
Stock-based compensation	$15M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.98
Book value per share	$11.78
Debt / EBITDA	3.58
Debt / equity	0.74
Goodwill	$197.6M
Interest coverage	1.86
Long-term assets	$466.9M
Long-term liabilities	$402.1M
Net cash (debt)	$-279.2M
Net cash / market cap	-35.9%
Net debt / EBITDA	2.81
Net debt / equity	0.55
Piotroski F-Score	6
Property, plant and equipment	$197M
Shareholders' equity	$510.5M
Tangible book value	$286.6M
Tangible book value per share	$6.80
Total assets	$1.1B
Total cash	$100.1M
Total debt	$379.3M
Total liabilities	$589.5M
WACC	9.17%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.8
Current assets	$633.1M
Current liabilities	$187.4M
Current ratio	3.38
Inventory turnover	1.76
Net working capital	$368.7M
Quick ratio	1.31
Working capital	$445.7M
Working capital turnover	1.95

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-2.55%
Dividend yield	0%
Shareholder yield	-2.55%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$13.75
1D price change	-0.03%
1M price change	0.05%
1M total return	0.05%
1W price change	0.33%
1W total return	0.33%
1Y price change	54.87%
1Y return CAGR	54.91%
1Y total return	54.87%
20-day SMA	$18.44
200-day SMA	$13.55
3M price change	68.12%
3M total return	68.12%
3Y price change	6.71%
3Y return CAGR	2.19%
3Y total return	6.71%
50-day SMA	$18.47
50-day SMA vs 200-day SMA	50over200
52-week high	$18.63
52-week high date	2026-08-11
52-week low	$9.09
52-week low date	2026-05-08
5Y price change	-30.13%
5Y return CAGR	-6.92%
5Y total return	-30.13%
6M price change	45.24%
6M total return	45.24%
All-time high	$43.76
All-time high date	2018-01-29
All-time low	$6.76
All-time low date	2025-05-09
Average true range (ATR)	$0.06
Average volume	525.6K
Beta (1Y)	1.4
Beta (2Y)	2.23
Beta (5Y)	0.97
Change from 52-week high	-0.94%
Change from 52-week low	103.03%
Change from all-time high	-57.82%
Change from all-time low	173.08%
Change from open	0.03%
Day's gap	-0.05%
Dollar volume	$8.5M
High price	$18.47
Low price	$18.45
Monthly RSI	61.82
Open price	$18.45
Position in 52-week range	25%
Premarket change	-0.27%
Premarket close	$18.46
Premarket price	$18.41
Previous close	$18.46
Price vs 150-day SMA	34.22%
Price vs 20-day SMA	0.09%
Price vs 200-day SMA	36.23%
Price vs 50-day SMA	-0.03%
Relative volume	0.87
RSI	63.83
Sharpe ratio	0.91
Sharpe ratio (3Y)	0.23
Sharpe ratio (5Y)	0
Sortino ratio	1.96
Sortino ratio (3Y)	0.46
Sortino ratio (5Y)	0.12
Volume	459.3K
Weekly RSI	75.37
YTD price change	58.46%
YTD total return	58.46%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	41.4M
Float percentage	98.27%
Shares change (QoQ)	1.43%
Shares change (YoY)	2.55%
Shares held by insiders	1.73%
Shares held by institutions	88.08%
Shares outstanding	42.1M
Short % of float	3.98%
Short % of shares	3.92%
Short ratio	2.4 days

Deeper analysis on VREX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VREX report

Is a complete VREX research report available?

No complete published report is available for Varex Imaging Corporation (VREX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Varex Imaging Corporation (VREX)

Price

Financial snapshot

Fair-value bridge

Latest news · VREX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VREX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VREX

Frequently asked questions